Winter 2022/2023 Vol. 12 Issue 04
-
From the Editor-in-Chief
Taking Aim at CancerTherapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
Finding Light in Winter’s DarknessColder temperatures, gray skies and shorter days can dampen the spirits, which can heighten sadness associated with cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Creating Calm in ChaosA prepacked bag of essential and not-so-essential items can provide structure and comfort to people with cancer during treatment.
by K.J. Bannan
-
Policy Matters
Stemming the E-Cigarette EpidemicAn updated AACR-ASCO joint statement recommends steps for policymakers to lower e-cigarette use among youth and young adults.
by Roy S. Herbst, MD, PhD
-
Cervical Cancer: A Global ChallengeLow- and middle-income countries make inroads against a preventable and treatable cancer.
by Erin O’Donnell
-
Mysterious MicrobesScientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
An Ongoing DiscussionPhysicians are often hesitant to bring up end-of-life care discussions with their patients. People being treated for cancer may need to frame questions to determine their own goals of care.
by Cameron Walker
-
Survivor Profile
Rising to the ChallengeJames R. Scott uses his experiences with bladder cancer to be a light for others.
by Lindsey Konkel Neabore
-
-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
Facts and Stats
Setting the StageUnderstanding your cancer’s stage is important for determining your prognosis and treatment options. Here’s what the different stages mean.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
